Navigation Links
AcelRx Pharmaceuticals Reports Fourth Quarter and Full-Year 2011 Financial Results
Date:3/20/2012

s a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain.  AcelRx's lead product candidate, the ARX-01 Sufentanil NanoTab PCA System, which is currently in Phase 3 clinical development, is designed to solve the problems associated with post-operative intravenous patient-controlled analgesia which has been shown to cause harm to patients following surgery because of the side effects of morphine, the invasive IV route of delivery and the inherent potential for programming and delivery errors associated with the complexity of infusion pumps.  AcelRx has two additional product candidates which have completed Phase 2 clinical development: ARX-02 for the treatment of cancer breakthrough pain, and ARX-03 for providing mild sedation, anxiety reduction and pain relief for patients undergoing painful procedures in a physician's office.  A fourth product candidate, ARX-04, is a sufentanil product for the treatment of moderate-to-severe acute pain that is expected to enter Phase 2 clinical development in the second quarter of 2012 under a grant from the USAMRMC.

Forward Looking Statements This press release contains forward-looking statements, including, but not limited to, statements related to AcelRx Pharmaceuticals' financial viability, anticipated increases in research and development and general and administrative expenses, the sufficiency of funds to support its clinical trials and operations, planned or anticipated future clinical development of AcelRx Pharmaceuticals' product candidates, including the anticipated timing for clinical trials, progress towards initiation of the remaining two Phase 3 studies for ARX-01 and the Phase 2 study for ARX-04, and the therapeutic and commercial potential of AcelRx Pharmaceuticals' product candidates. These forward-looking statements are based on AcelRx Pharmaceuticals' current expectations and inherently in
'/>"/>

SOURCE AcelRx Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. AcelRx Pharmaceuticals Reports Positive Results from a Clinical Trial of Sublingual Sufentanil/Triazolam NanoTab(TM) Combination (ARX-03) in Treating Procedural Pain and Anxiety
2. AcelRx Initiates a Phase 2 Study to Evaluate Functionality of Its ARX-01 Sufentanil NanoTab PCA System
3. AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain
4. AcelRx Programs to be Featured in Oral Presentations at the American Society of Anesthesiologists 2009 Annual Meeting
5. AcelRx to Present at the Lazard 6th Annual Healthcare Conference
6. AcelRx Announces Positive Phase 2 Results From a Study of ARX-02 Sufentanil NanoTab(TM) Breakthrough Pain Management System in Treating Cancer Breakthrough Pain
7. AcelRx Pharmaceuticals Files Registration Statement for Proposed Initial Public Offering
8. AcelRx Pharmaceuticals Announces Pricing of Its Initial Public Offering
9. AcelRx Pharmaceuticals to Present at the Cowen and Company 31st Annual Health Care Conference
10. AcelRx Pharmaceuticals Reports Fourth Quarter and Full-Year 2010 Financial Results
11. AcelRx Pharmaceuticals to Present at the JMP Securities Research Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... SAN FRANCISCO , June 29, 2015 ... 47.54 billion by 2020, according to a new study by Grand ... II diabetes and the presence of high unmet needs in emerging ... China are expected to be two of the most ... lifestyle induced diseases such as obesity and growing global geriatric population ...
(Date:6/29/2015)... CITY, Mo. , June 29, 2015  Missouri ... the 2015 first quarter data from the state,s real-time, ... (NPLEx). States across the United ... Missouri one of 31 across the country ... attempted pseudoephedrine (PSE) purchases at the point of sale.  ...
(Date:6/29/2015)... KING OF PRUSSIA, Pa. , June 29, 2015 ... Alsharabati, MD, University of Alabama at Birmingham, ... 2015 Interlaken Leadership Award for ... global awards program provides monetary grants and/or product supply ... potential role of immunoglobulin (Ig) therapy in the treatment ...
Breaking Medicine Technology:Insulin Market To Reach $47.54 Billion By 2020: Grand View Research, Inc. 2Insulin Market To Reach $47.54 Billion By 2020: Grand View Research, Inc. 3Insulin Market To Reach $47.54 Billion By 2020: Grand View Research, Inc. 4CSL Behring Announces the 2015 Interlaken Leadership Awards Recipient 2CSL Behring Announces the 2015 Interlaken Leadership Awards Recipient 3
... 5, 2011 In its April issue, published this ... magazine has announced the winners of the fourteenth annual ... (Logo:  https://photos.prnewswire.com/prnh/20101214/LA16070LOGO) Sponsored by MD+DI ... the premier awards program for the medical technology community. ...
... April 5, 2011 RESMED INC. (NYSE: RMD ... will release its results for the third quarter and nine ... press release with ResMed,s results will be issued after 1:00 ... call and webcast to review its results, market trends, and ...
Cached Medicine Technology:37 Innovative Products Win Medical Design Excellence Awards 237 Innovative Products Win Medical Design Excellence Awards 337 Innovative Products Win Medical Design Excellence Awards 4ResMed Announces Conference Call and Webcast to Discuss Third Quarter 2011 Results 2
(Date:6/30/2015)... ... 30, 2015 , ... The American Psychiatric Nurses Association ... Coronado Springs Resort in Lake Buena Vista, Florida, and will offer more than ... for psychiatric-mental health nursing draws more than 1,500 health care professionals from around ...
(Date:6/30/2015)... ... 30, 2015 , ... This Fourth of July, Peacock Alley celebrates ... hard work, tenacity, perseverance, commitment to quality, honesty and love of friends and family. ... Ella Gabler's simple love of quilts, Peacock Alley was fully realized and grown while ...
(Date:6/29/2015)... ... , ... Sublime Beauty NATURALS® introduces its new USDA Certified Organic Sesame Oil ... skincare and even culinary uses, was especially designed for Oil Pulling. , To ... Pulling can accomplish this. Oil Pulling is an Ayurvedic practice that is easy and ...
(Date:6/29/2015)... ... June 30, 2015 , ... With thousands of children in Utah Valley ... much-needed autism support center, planned at Utah Valley University, in Orem, Utah. The ... center and the building in which it will be housed. , Utah Valley has ...
(Date:6/29/2015)... ... June 29, 2015 , ... ... spine surgeon, Dr. John A. Mitamura, MD., PhD into their world-class multidisciplinary team ... locations including Long Beach , Irwindale and La Tijera-Los Angeles. , ...
Breaking Medicine News(10 mins):Health News:American Psychiatric Nurses Association 29th Annual Conference: Continuing Education and Collaboration in Psychiatric-Mental Health and Nursing 2Health News:American Psychiatric Nurses Association 29th Annual Conference: Continuing Education and Collaboration in Psychiatric-Mental Health and Nursing 3Health News:Luxury Linen Purveyor Peacock Alley Celebrates the Fourth of July 2Health News:New Product: Transform Wellness and Oral Health With This Ancient Ayurvedic Secret and Organic Product from Sublime Beauty NATURALS® 2Health News:doTERRA Partners With Utah Valley University on Autism Support Center 2Health News:doTERRA Partners With Utah Valley University on Autism Support Center 3Health News:Renowned Orthopedic and Spine Surgeon Joins Healthpointe in Long Beach 2Health News:Renowned Orthopedic and Spine Surgeon Joins Healthpointe in Long Beach 3
... Data published in the June issue of the ... biospectroscopy was able to identify changes in oxidative stress ... be a useful biomarker in the early detection of ... for diagnosing Alzheimer,s disease. Researchers at McGill University ...
... June 12, 2009 -- The Association for Molecular ... letter it has provided to the Federal Coordinating Council ... forth its recommendations for priority areas on which to ... in Congress and among other policy makers who see ...
... June 16 The U.S. Food and Drug Administration (FDA) ... draft guidance for the food industry, developed in response to ... of 2007 (Pub. L.110-085). The RFR is scheduled for implementation ... of foods, including dietary supplements. Only infant formula is exempt ...
... is a clinically proven, anti-aging beauty infusion that greatly improves ... nails . In comprehensive multicenter clinical trials, 86% of ... within 3 weeks*! , , To view the Multimedia ... , (Photo: http://www.newscom.com/cgi-bin/prnh/20090616/NY32948 ) , ...
... U.S. Department of Energy,s (DOE) Brookhaven National Laboratory have demonstrated ... developed into a method for early diagnosis of Alzheimer,s disease. ... in breast tissue and cartilage in human knee and ankle ... ability to visualize a class of miniscule plaques that are ...
... the Addiction Treatment Gap (CATG) Poll Shows Widespread Concern about ... June 16 A new poll conducted for ... regardless of race, age, where people live or income, most ... or drugs, are worried about access to affordable treatment and ...
Cached Medicine News:Health News:New data demonstrate potential for early detection of Alzheimer's disease 2Health News:AMP urges inclusion of molecular diagnostic tests in comparative effectiveness research 2Health News:AMP urges inclusion of molecular diagnostic tests in comparative effectiveness research 3Health News:Reportable Food Registry Draft Guidance Published for Comment by FDA 2Health News:Video: 'BeautyScoop(R) Is a Trip to Your Nutritionist and Dermatologist in One Single Packet.' Lauren Slayton, NYC Nutritionist & Owner of FoodTrainers 2Health News:X-rays for early Alzheimer's disease detection 2Health News:X-rays for early Alzheimer's disease detection 3Health News:New Poll Finds Most Americans Support Including Treatment for Drug and Alcohol Addiction in National Health Care Reform; All Demographics Report Personal Experience With the Disease 2Health News:New Poll Finds Most Americans Support Including Treatment for Drug and Alcohol Addiction in National Health Care Reform; All Demographics Report Personal Experience With the Disease 3Health News:New Poll Finds Most Americans Support Including Treatment for Drug and Alcohol Addiction in National Health Care Reform; All Demographics Report Personal Experience With the Disease 4
The Antibacterial Personal Catheter® features a unique silicone composition that provides an antibacterial coated soft outer layer of silicone combined with a firm inner layer....
The Gizmo male external catheter is a latex catheter that uses a single-sided adhesive strip....
... Rochester Medical's line of ... intermittent catheters you would ... four product configurations - ... antibacterial hydro - are ...
... The Mentor Freedom Pak Seven ... packaged week's supply of Freedom ... kit all 100% latex-free ... wipes for your convenience and ...
Medicine Products: